Business
Idaho Falls site added to RTX-2358 manufacturing plan
PharmaLogic will expand production capacity for Ratio Therapeutics’ Ac-225 RTX-2358 as the FAP-targeted radiopharmaceutical moves through ATLAS clinical testing.
Company
PharmaLogic
Business
PharmaLogic Atlanta site expands PET radiopharma capacity
PharmaLogic opened a PET radiopharmaceutical manufacturing facility in Atlanta to expand production and distribution across the Southeast. The site is part of a $250M U.S. infrastructure investment.